Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults.
暂无分享,去创建一个
[1] Jane Mummery,et al. Regional , 2019, M/C Journal.
[2] Jorge Sepulcre,et al. Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals , 2018, Nature Neuroscience.
[3] Theresa M. Harrison,et al. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging , 2017, The Journal of Neuroscience.
[4] W. Jagust,et al. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data , 2017, Data in brief.
[5] Reisa A. Sperling,et al. The association between tau PET and retrospective cortical thinning in clinically normal elderly , 2017, NeuroImage.
[6] William J. Jagust,et al. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease , 2017, NeuroImage.
[7] Keith A. Johnson,et al. Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals , 2017, The Journal of Neuroscience.
[8] W. Jagust,et al. Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging , 2017, The Journal of Neuroscience.
[9] Jorge Sepulcre,et al. Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline , 2017, Annals of neurology.
[10] Gereon R. Fink,et al. Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease , 2016, Annals of clinical and translational neurology.
[11] Hanna Cho,et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum , 2016, Annals of neurology.
[12] S. A. Hussaini,et al. Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.
[13] Yi Su,et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease , 2016, Science Translational Medicine.
[14] Daniel R. Schonhaut,et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.
[15] Daniel R. Schonhaut,et al. PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.
[16] Sylvia Richardson,et al. A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies , 2016, Science Translational Medicine.
[17] N. Albert,et al. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study , 2016, The Journal of Nuclear Medicine.
[18] Anirvan Ghosh,et al. Specification of synaptic connectivity by cell surface interactions , 2015, Nature Reviews Neuroscience.
[19] E. Mandelkow,et al. Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.
[20] W. Jagust,et al. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. , 2015, Brain : a journal of neurology.
[21] Keith A. Johnson,et al. Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.
[22] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[23] Daniel R. Schonhaut,et al. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy , 2015, Annals of neurology.
[24] Janna H. Neltner,et al. Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.
[25] D. Y. Lee,et al. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[26] Cindee M. Madison,et al. Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? , 2014, Cerebral cortex.
[27] C. Jack,et al. Association of hypometabolism and amyloid levels in aging, normal subjects , 2014, Neurology.
[28] Cindee M. Madison,et al. Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly , 2014, Human brain mapping.
[29] H. Kolb,et al. [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease , 2013, Alzheimer's & Dementia.
[30] Zhenghui Hu,et al. The Relationship between Cerebral Glucose Metabolism and Age: Report of a Large Brain PET Data Set , 2012, PloS one.
[31] W. Jagust,et al. Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging , 2012, The Journal of Neuroscience.
[32] G. Chételat,et al. Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease Dementia , 2012, The Journal of Neuroscience.
[33] D. Attwell,et al. Synaptic Energy Use and Supply , 2012, Neuron.
[34] Naruhiko Sahara,et al. Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.
[35] B. Miller,et al. Cognition, glucose metabolism and amyloid burden in Alzheimer's disease , 2012, Neurobiology of Aging.
[36] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[37] Michael D. Greicius,et al. Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. , 2011, Cerebral cortex.
[38] M. Weiner,et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. , 2010, Brain : a journal of neurology.
[39] R. Tibshirani,et al. A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. , 2009, Biostatistics.
[40] M. Witter,et al. What Does the Anatomical Organization of the Entorhinal Cortex Tell Us? , 2008, Neural plasticity.
[41] H. Rusinek,et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[42] J. Baron,et al. Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[43] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] Akihiko Takashima,et al. Alterations in Glucose Metabolism Induce Hypothermia Leading to Tau Hyperphosphorylation through Differential Inhibition of Kinase and Phosphatase Activities: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.
[45] Jean-Claude Baron,et al. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons , 2003, NeuroImage.
[46] W. Härdle,et al. Applied Multivariate Statistical Analysis , 2003 .
[47] W. Klunk,et al. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.
[48] J. Baron,et al. Efficient principal component analysis for multivariate 3D voxel‐based mapping of brain functional imaging data sets as applied to FDG‐PET and normal aging , 2003, Human brain mapping.
[49] J. Logan. Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.
[50] J. Morrison,et al. Determinants of neuronal vulnerability in neurodegenerative diseases , 1998, Annals of neurology.
[51] A. Evans,et al. Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[52] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[53] H. Braak,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[54] M. Bobinski,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[55] D. Pandya,et al. Some observations on the course and composition of the cingulum bundle in the rhesus monkey , 1984, The Journal of comparative neurology.
[56] H. Hotelling. Relations Between Two Sets of Variates , 1936 .
[57] D. Y. Lee,et al. Association of Cerebral Amyloid-&bgr; Aggregation With Cognitive Functioning in Persons Without Dementia , 2018, JAMA psychiatry.
[58] A. A. Farooqui,et al. Slow excitotoxicity in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[59] Udo Rüb,et al. Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. , 2006, Journal of Alzheimer's disease : JAD.
[60] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.